Cytek Biosciences, Inc. announced the appointment of Philippe Busque, Ph.D. as Senior Vice President of Global Sales & Services. In this newly created position, Dr. Busque will lead an enhanced global sales organization encompassing all customer facing functions worldwide, including sales, service, and technical application support, building on the recently integrated sales team that combines the original Cytek sales force with the Amnis® and Guava® sales force. Cytek?s acquisition of the Amnis and Guava product lines from Luminex Corporation in February 2023 provided the Company with expanded market access, new product development opportunities, and operational synergies.

To take advantage of these expanded market and product development opportunities, Cytek is reorganizing its Commercial function into two distinct operations: the enhanced sales organization led by Dr. Busque, and a new Platform organization, which will encompass marketing, product roadmaps, and program management. The Company believes the new structure will support the Company?s transition toward a market-driven organization and to develop and sell cell analysis solutions based on market-derived inputs. These market inputs will shape Cytek?s research, new product, and applications development, and its approach to interacting with customers.